ZA895838B - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
ZA895838B
ZA895838B ZA895838A ZA895838A ZA895838B ZA 895838 B ZA895838 B ZA 895838B ZA 895838 A ZA895838 A ZA 895838A ZA 895838 A ZA895838 A ZA 895838A ZA 895838 B ZA895838 B ZA 895838B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
ZA895838A
Other languages
English (en)
Inventor
John Joseph Nestor
Joseph Nestor John
Brian Henry Vickery
Henry Vickery Brian
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA895838B publication Critical patent/ZA895838B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA895838A 1988-08-18 1989-07-31 Pharmaceutical compounds ZA895838B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23369088A 1988-08-18 1988-08-18

Publications (1)

Publication Number Publication Date
ZA895838B true ZA895838B (en) 1991-03-27

Family

ID=22878305

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895838A ZA895838B (en) 1988-08-18 1989-07-31 Pharmaceutical compounds

Country Status (11)

Country Link
EP (1) EP0363589A3 (da)
JP (1) JPH0273100A (da)
KR (1) KR900003205A (da)
AU (1) AU3926589A (da)
DK (1) DK375789A (da)
FI (1) FI893643A7 (da)
HU (1) HUT50487A (da)
IL (1) IL91166A0 (da)
NO (1) NO893088L (da)
PT (1) PT91384A (da)
ZA (1) ZA895838B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
ATE124054T1 (de) * 1990-04-06 1995-07-15 Univ Tulane Somatostatinanaloge.
ATE181240T1 (de) * 1991-02-08 1999-07-15 Biomeasure Inc Verwendung von somatostatinanalogen zur behandlung von melanomen
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
HU224350B1 (hu) 1993-08-09 2005-08-29 Société de Conseils de Recherches et d'ApplicationScientifiques, S.A.S. Á Gyógyhatású peptidszármazékok
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
EP0981364B1 (en) 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
CA2290592A1 (en) 1997-05-13 1998-11-19 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for decreasing body weight
CA2289499C (en) * 1997-05-13 2010-02-23 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
NZ530007A (en) 2001-06-08 2006-02-24 Sod Conseils Rech Applic Somatostatin-dopamine chimeric analogues that retain both somatostatin and dopamine activity in vivo and display enhanced biological activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
WO2009150470A2 (en) 2008-06-12 2009-12-17 Syntaxin Limited Suppression of cancers
EP2310028B1 (en) 2008-06-12 2016-11-16 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP3007704B1 (en) 2013-06-13 2021-01-06 Antisense Therapeutics Ltd Combination therapy for acromegaly
CN108174843B (zh) * 2018-01-24 2018-11-13 广州市进德生物科技有限公司 一种胰高血糖素保护剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
IL60214A0 (en) * 1979-06-11 1980-09-16 Lilly Co Eli Peptides related to somatostatin
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs

Also Published As

Publication number Publication date
JPH0273100A (ja) 1990-03-13
FI893643L (fi) 1990-02-19
PT91384A (pt) 1990-03-08
DK375789D0 (da) 1989-07-31
FI893643A7 (fi) 1990-02-19
EP0363589A3 (en) 1990-08-16
AU3926589A (en) 1990-02-22
NO893088D0 (no) 1989-07-31
EP0363589A2 (en) 1990-04-18
KR900003205A (ko) 1990-03-26
DK375789A (da) 1990-02-19
IL91166A0 (en) 1990-03-19
NO893088L (no) 1990-02-19
FI893643A0 (fi) 1989-08-01
HUT50487A (en) 1990-02-28

Similar Documents

Publication Publication Date Title
ZA875813B (en) Pharmaceutical compounds
ZW1989A1 (en) Compounds
GB8800891D0 (en) Pharmaceutical compounds
GB8924052D0 (en) Pharmaceutical solution
GB8916682D0 (en) Pharmaceutical compounds
ZA893422B (en) Pharmaceutical composition
ZA899948B (en) Pharmaceutical preparation
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
CS343490A3 (en) Pharmaceutical
GB8807505D0 (en) Pharmaceutical combinations
GB8819490D0 (en) Pharmaceutical devices
GB8826204D0 (en) Pharmaceutical compounds
GB8830078D0 (en) Pharmaceutical compounds
GB8906262D0 (en) Pharmaceutical compounds
GB8904040D0 (en) Pharmaceutical compounds
GB8920738D0 (en) Pharmaceutical compounds
GB8911196D0 (en) Pharmaceutical compounds
IE881532L (en) Pharmaceutical mixtures
IE872126L (en) Pharmaceutical compounds
GB8805076D0 (en) Pharmaceutical combinations
GB8808838D0 (en) Pharmaceutical combinations
GB8805077D0 (en) Pharmaceutical combinations
GB8802927D0 (en) Pharmaceutical composition
GB8818098D0 (en) Pharmaceutical composition
GB8806495D0 (en) Pharmaceutical composition